Cargando…

Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial—STORM STUDY

Nonsteroidal anti-inflammatory drugs (NSAIDs) have gastrointestinal side effects such as dyspepsia, peptic ulcer, hemorrhage, and perforation. Misoprostol and PPIs have been used to prevent NSAID-induced gastroduodenal injury. Rebamipide increases gastric mucus and stimulates the production of endog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Soo-Heon, Cho, Chul-Soo, Lee, Oh-Young, Jun, Jae-Bum, Lin, San-Ren, Zhou, Li-Ya, Yuan, Yao-Zong, Li, Zhao-Shen, Hou, Xiao-Hua, Zhao, Hong-Chuan, Kachintorn, Udom, Kositchaiwat, Chomsri, Lertkupinit, Comson
Formato:	Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127224/ https://www.ncbi.nlm.nih.gov/pubmed/18188417 http://dx.doi.org/10.3164/jcbn.40.148

Ejemplares similares

Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADER
por: Imai, Toru, et al.
Publicado: (2022)

Normal Solid Gastric Emptying Values Measured by Scintigraphy Using Asian-style Meal:A Multicenter Study in Healthy Volunteers
por: Vasavid, Pataramon, et al.
Publicado: (2014)

A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
por: Lee, Oh Young, et al.
Publicado: (2014)

Erratum to: A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
por: Lee, Oh Young, et al.
Publicado: (2014)

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
por: Park, Sejeong, et al.
Publicado: (2016)

Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms
por: Mizukami, Kazuhiro, et al.
Publicado: (2012)

Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase
por: Tanigawa, Tetsuya, et al.
Publicado: (2011)

Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity
por: Kim, Jeong Ho, et al.
Publicado: (2014)

The impact of introducing the early warning scoring system and protocol on clinical outcomes in tertiary referral university hospital
por: Sutherasan, Yuda, et al.
Publicado: (2018)

Value of age and alarm features for predicting upper gastrointestinal malignancy in patients with dyspepsia: an endoscopic database review of 4664 patients in Thailand
por: Kaosombatwattana, Uayporn, et al.
Publicado: (2021)

Prevention of NSAID-Associated Gastroduodenal Injury in Healthy Volunteers-A Randomized, Double-Blind, Multicenter Study Comparing DA-9601 with Misoprostol
por: Lee, Kang Nyeong, et al.
Publicado: (2011)

The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
por: Hong, Su Jin, et al.
Publicado: (2016)

Solid Nanocrystals of Rebamipide Promote Recovery from Indomethacin-Induced Gastrointestinal Bleeding
por: Nagai, Noriaki, et al.
Publicado: (2019)

Outcome of Acute Upper Gastrointestinal Bleeding in Patients with Coronary Artery Disease: A Matched Case–control Study
por: Thanapirom, Kessarin, et al.
Publicado: (2016)

Propofol-based deep sedation for endoscopic retrograde cholangiopancreatography procedure in sick elderly patients in a developing country
por: Amornyotin, Somchai, et al.
Publicado: (2011)

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs
por: Peura, David A, et al.
Publicado: (2005)

Treatment and chemoprevention of NSAID-associated gastrointestinal complications
por: Frech, Edward J, et al.
Publicado: (2009)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
por: McEvoy, L., et al.
Publicado: (2021)

Management of NSAID Associated Upper Gastrointestinal Problems
por: Cryer, Byron
Publicado: (2005)

A Case-Control Study of Esomeprazole Plus Rebamipide vs. Omeprazole Plus Rebamipide on Post-ESD Gastric Ulcers
por: Bunno, Maki, et al.
Publicado: (2013)

A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers
por: Yan, Bin, et al.
Publicado: (2019)

Rebamipide and mosapride enhance pilocarpine-induced salivation
por: Urita, Yoshihisa, et al.
Publicado: (2009)

Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013)

Topical rebamipide improves lid wiper epitheliopathy
por: Itakura, Hirotaka, et al.
Publicado: (2013)

Prescription Pattern of NSAIDs and the Prevalence of NSAID-induced Gastrointestinal Risk Factors of Orthopaedic Patients in Clinical Practice in Korea
por: Lee, Sung-Hun, et al.
Publicado: (2011)

Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review
por: Sohail, Rohab, et al.
Publicado: (2023)

Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial
por: Eom, Youngsub, et al.
Publicado: (2023)

Topical rebamipide improves the ocular surface in mild lagophthalmos
por: Itakura, Mariko, et al.
Publicado: (2013)

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation
por: Jhun, JooYeon, et al.
Publicado: (2017)

Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
por: Pongpit, Jamrus, et al.
Publicado: (2016)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Foley catheter plus misoprostol versus misoprostol alone for labor induction
por: Elpo, Jhonathan Alcides, et al.
Publicado: (2023)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection
por: Ichida, Takashi, et al.
Publicado: (2018)

Efficacy of Teprenone for Prevention of NSAID-Induced Gastrointestinal Injury: A Systematic Review and Meta-Analysis
por: Zhao, Chongxiang, et al.
Publicado: (2021)

Resolution of persistent corneal erosion after administration of topical rebamipide
por: Kashima, Tomoyuki, et al.
Publicado: (2012)

Rebamipide Delivered by Brushite Cement Enhances Osteoblast and Macrophage Proliferation
por: Pujari-Palmer, Michael, et al.
Publicado: (2015)

Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye
por: Igarashi, Tsutomu, et al.
Publicado: (2018)

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
por: Shrivastava, Saurabh, et al.
Publicado: (2018)

Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury
por: Ota, Kazuhiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q5b56cv6qcscu6egbf1gh8leba